Association of fatty acid binding protein-4 (FABP-4) T87C and rs8192688 gene polymorphisms and FABP-4 level with cardiovascular disease susceptibility in type 2 diabetic patients

References

• World Health Organization. About Diabetes. World Health Organization, 2014.
   Google Scholar
• International Diabetes Federation. IDF Diabetes Atlas. 10th ed. International Diabetes Federation, 2021.
   Google Scholar
• Bakhtiyari, A.; Haghani, K.; Bakhtiyari, S.; Zaimy, M. A.; Noori-Zadeh, A.; Gheysarzadeh, A.; Darabi, S.; Seidkhani-Nahal, A.; Amraei, M.; Alipourfard, I. Association between ABCC8 Ala1369Ser Polymorphism (rs757110 T/G) and Type 2 Diabetes Risk in an Iranian Population: A Case-Control Study. Endocr. Metab. Immune Disorders Drug Targets 2020.
   Web of Science ®Google Scholar
• Chapman, M. J.; Ginsberg, H. N.; Amarenco, P.; Andreotti, F.; Borén, J.; Catapano, A. L.; Descamps, O. S.; Fisher, E.; Kovanen, P. T.; Kuivenhoven, J. A.; et al. Triglyceride-Rich Lipoproteins and High-Density Lipoprotein Cholesterol in Patients at High Risk of Cardiovascular Disease: Evidence and Guidance for Management. Eur. Heart J. 2011, 32, 1345–1361. DOI: 10.1093/eurheartj/ehr112.
   PubMed Web of Science ®Google Scholar
• Shlomo Melmed, K. P.; Reed Larsen, P.; Kronenberg, H. Williams Textbook of Endocrinology, Philadelphia, Pennsylvania, USA. 2011, 1920–1946.
   Google Scholar
• Risérus, U.; Willett, W. C.; Hu, F. B. Dietary Fats and Prevention of Type 2 Diabetes. Prog. Lipid. Res. 2009, 48, 44–51. DOI: 10.1016/j.plipres.2008.10.002.
   PubMed Web of Science ®Google Scholar
• Herder, C.; Roden, M. Genetics of Type 2 Diabetes: Pathophysiologic and Clinical Relevance. Eur. J. Clin. Invest. 2011, 41, 679–692. DOI: 10.1111/j.1365-2362.2010.02454.x.
   PubMed Web of Science ®Google Scholar
• Lyssenko, V.; Jonsson, A.; Almgren, P.; Pulizzi, N.; Isomaa, B.; Tuomi, T.; Berglund, G.; Altshuler, D.; Nilsson, P.; Groop, L. Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes. N. Engl. J. Med. 2008, 359, 2220–2232. DOI: 10.1056/NEJMoa0801869.
   PubMed Web of Science ®Google Scholar
• McCarthy, M. I. Genomics, Type 2 Diabetes, and Obesity. N. Engl. J. Med. 2010, 363, 2339–2350. DOI: 10.1056/NEJMra0906948.
   PubMed Web of Science ®Google Scholar
• Ayub, Q.; Moutsianas, L.; Chen, Y.; Panoutsopoulou, K.; Colonna, V.; Pagani, L.; Prokopenko, I.; Ritchie, G. R. S.; Tyler-Smith, C.; McCarthy, M. I.; et al. Revisiting the Thrifty Gene Hypothesis via 65 Loci Associated with Susceptibility to Type 2 Diabetes. Am. J. Hum. Genet. 2014, 94, 176–185. DOI: 10.1016/j.ajhg.2013.12.010.
   PubMed Web of Science ®Google Scholar
• Wellen, K. E.; Hotamisligil, G. S. Inflammation, Stress, and Diabetes. J. Clin. Invest. 2005, 115, 1111–1119. DOI: 10.1172/JCI25102.
   PubMed Web of Science ®Google Scholar
• Schofield, J. D.; Liu, Y.; Rao-Balakrishna, P.; Malik, R. A.; Soran, H. Diabetes Dyslipidemia. Diabetes Ther. 2016, 7, 203–219. DOI: 10.1007/s13300-016-0167-x.
   PubMed Web of Science ®Google Scholar
• Ishimura, S.; Furuhashi, M.; Watanabe, Y.; Hoshina, K.; Fuseya, T.; Mita, T.; Okazaki, Y.; Koyama, M.; Tanaka, M.; Akasaka, H.; et al. Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population. PLoS One 2013, 8, e81318. DOI: 10.1371/journal.pone.0081318.
   PubMed Web of Science ®Google Scholar
• Furuhashi, M.; Hotamisligil, G. S. Fatty Acid-Binding Proteins: Role in Metabolic Diseases and Potential as Drug Targets. Nat. Rev. Drug Discovery 2008, 7, 489–503. DOI: 10.1038/nrd2589.
   PubMed Web of Science ®Google Scholar
• Xu, A.; Wang, Y.; Xu, J. Y.; Stejskal, D.; Tam, S.; Zhang, J.; Wat, N. M.; Wong, W. K.; Lam, K. S. Adipocyte Fatty Acid-Binding Protein is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome. Clin. Chem. 2006, 52, 405–413. DOI: 10.1373/clinchem.2005.062463.
   PubMed Web of Science ®Google Scholar
• Xu, A.; Tso, A. W.; Cheung, B. M.; Wang, Y.; Wat, N. M.; Fong, C. H.; Yeung, D. C.; Janus, E. D.; Sham, P. C.; Lam, K. S. Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict the Development of the Metabolic Syndrome: A 5-Year Prospective Study. Circulation 2007, 115, 1537–1543. DOI: 10.1161/CIRCULATIONAHA.106.647503.
   PubMed Web of Science ®Google Scholar
• Tso, A. W.; Xu, A.; Sham, P. C.; Wat, N. M.; Wang, Y.; Fong, C. H.; Cheung, B. M.; Janus, E. D.; Lam, K. S. Serum Adipocyte Fatty Acid Binding Protein as a New Biomarker Predicting the Development of Type 2 Diabetes: A 10-Year Prospective Study in a Chinese Cohort. Diabetes Care 2007, 30, 2667–2672. DOI: 10.2337/dc07-0413.
   PubMed Web of Science ®Google Scholar
• Yeung, D. C.; Xu, A.; Cheung, C. W.; Wat, N. M.; Yau, M. H.; Fong, C. H.; Chau, M. T.; Lam, K. S. Serum Adipocyte Fatty Acid-Binding Protein Levels Were Independently Associated with Carotid Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1796–1802. DOI: 10.1161/ATVBAHA.107.146274.
   PubMed Web of Science ®Google Scholar
• Maeda, K.; Cao, H.; Kono, K.; Gorgun, C. Z.; Furuhashi, M.; Uysal, K. T.; Cao, Q.; Atsumi, G.; Malone, H.; Krishnan, B.; et al. Adipocyte/Macrophage Fatty Acid Binding Proteins Control Integrated Metabolic Responses in Obesity and Diabetes. Cell Metab. 2005, 1, 107–119. DOI: 10.1016/j.cmet.2004.12.008.
   PubMed Web of Science ®Google Scholar
• Hotamisligil, G. S.; Bernlohr, D. A. Metabolic Functions of FABPs–Mechanisms and Therapeutic Implications. Nat. Rev. Endocrinol. 2015, 11, 592–605. DOI: 10.1038/nrendo.2015.122.
   PubMed Web of Science ®Google Scholar
• Saberi, H.; Mohammadtaghvaei, N.; Gulkho, S.; Bakhtiyari, S.; Mohammadi, M.; Hanachi, P.; Gerayesh-Nejad, S.; Zargari, M.; Ataei, F.; Parvaneh, L.; et al. The ENPP1 K121Q Polymorphism is Not Associated with Type 2 Diabetes and Related Metabolic Traits in an Iranian Population. Mol. Cell Biochem. 2011, 350, 113–118. DOI: 10.1007/s11010-010-0687-z.
   PubMed Web of Science ®Google Scholar
• Matthews, D. R.; Hosker, J. P.; Rudenski, A. S.; Naylor, B. A.; Treacher, D. F.; Turner, R. C. Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man. Diabetologia 1985, 28, 412–419. DOI: 10.1007/BF00280883.
   PubMed Web of Science ®Google Scholar
• Sasieni, P. D. From Genotypes to Genes: Doubling the Sample Size. Biometrics 1997, 53, 1253–1261.
   PubMed Web of Science ®Google Scholar
• Eliasson, B.; Gudbjörnsdottir, S.; Zethelius, B.; Eeg-Olofsson, K.; Cederholm, J. LDL-Cholesterol versus Non-HDL-to-HDL-Cholesterol Ratio and Risk for Coronary Heart Disease in Type 2 Diabetes. Eur. J. Prev. Cardiol. 2014, 21, 1420–1428. DOI: 10.1177/2047487313494292.
   PubMed Web of Science ®Google Scholar
• Ye, X.; Kong, W.; Zafar, M. I.; Chen, L.-L. Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Prospective Studies. Cardiovasc. Diabetol. 2019, 18, 48. DOI: 10.1186/s12933-019-0851-z.
   PubMed Web of Science ®Google Scholar
• Lu, W.; Resnick, H. E.; Jablonski, K. A.; Jones, K. L.; Jain, A. K.; Howard, W. J.; Robbins, D. C.; Howard, B. V. Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes: The Strong Heart Study. Diabetes Care 2003, 26, 16–23. DOI: 10.2337/diacare.26.1.16.
   PubMed Web of Science ®Google Scholar
• Cavero-Redondo, I.; Peleteiro, B.; Álvarez-Bueno, C.; Rodriguez-Artalejo, F.; Martínez-Vizcaíno, V. Glycated Haemoglobin A1c as a Risk Factor of Cardiovascular Outcomes and All-Cause Mortality in Diabetic and Non-Diabetic Populations: A Systematic Review and Meta-Analysis. BMJ Open 2017, 7, e015949. DOI: 10.1136/bmjopen-2017-015949.
   PubMed Web of Science ®Google Scholar
• Tuncman, G.; Erbay, E.; Hom, X.; De Vivo, I.; Campos, H.; Rimm, E. B.; Hotamisligil, G. A Genetic Variant at the Fatty Acid-Binding Protein aP2 Locus Reduces the Risk for Hypertriglyceridemia, Type 2 Diabetes, and Cardiovascular Disease. Proc. Natl. Acad. Sci. USA 2006, 103, 6970–6975. DOI: 10.1073/pnas.0602178103.
   PubMed Web of Science ®Google Scholar
• Mansego, M. L.; Martínez, F.; Martínez-Larrad, M. T.; Zabena, C.; Rojo, G.; Morcillo, S.; Soriguer, F.; Martín-Escudero, J. C.; Serrano-Ríos, M.; Redon, J.; Chaves, F. J. Common Variants of the Liver Fatty Acid Binding Protein Gene Influence the Risk of Type 2 Diabetes and Insulin Resistance in Spanish Population. PLoS One 2012, 7, e31853. DOI: 10.1371/journal.pone.0031853.
   PubMed Web of Science ®Google Scholar
• Ibarretxe, D.; Girona, J.; Plana, N.; Cabre, A.; Heras, M.; Ferre, R.; Merino, J.; Vallvé, J.; Masana, L. FABP4 Plasma Concentrations Are Determined by Acquired Metabolic Derangements Rather than Genetic Determinants. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 875–880. DOI: 10.1016/j.numecd.2015.05.008.
   PubMed Web of Science ®Google Scholar